Use of recombinant spider silk protein
By inhibiting the activity of hyaluronidase and elastase by recombinant spider silk proteins, the problems of poor anti-wrinkle and anti-allergic effects of skin care and insufficient strength of hair bundles in the prior art have been solved, and more effective skin and hair care has been achieved Effect.
Patent Information
- Application Number
- CN202311669459.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-12-07
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2043-12-07
AI Technical Summary
Existing skin care products are not effective in anti-wrinkle and anti-skin allergies, and hair care products are difficult to improve hair strand strength.
Recombinant spider silk protein is used to prepare products that soothe skin, resist skin allergies, anti-wrinkle, firm the skin and improve hair bundle strength by inhibiting hyaluronidase and elastase activities, as well as enhancing the tensile load of hair bundles and breaking capability.
Recombinant spider silk protein significantly inhibits hyaluronidase and elastase activities, improves skin health and enhances hair bundle strength, and provides more effective skin and hair care effects.
Smart Images

Figure CN117357427B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of cosmetics, and in particular to a use of recombinant spider silk protein. Background Art
[0002] As the first line of defense for the human body, the skin protects internal organs from changes in temperature and humidity, ultraviolet rays, pollutants and other external environmental stimuli. Due to factors such as aging, environment, and irregular lifestyle, the skin will change due to internal and external factors, such as wrinkles, sagging, dullness, pigmentation, itching and allergies.
[0003] Skin aging is mainly affected by both intrinsic and extrinsic factors. Endogenous skin aging is determined by individual genetic background factors. Extrinsic aging is caused by external factors, such as smoking, excessive drinking, malnutrition and long-term exposure to sunlight. From the external aspect, the skin is the outermost layer of the living body and plays a protective role. Therefore, the cumulative damage caused by environmental factors is considered to be the main cause of skin aging. In particular, ultraviolet rays are considered to be the most serious environmental factor. Under the stimulation of ultraviolet rays, the expression and activity of matrix metalloproteinases (MMPs) in the skin continue to increase. MMPs are a class of enzymes that can degrade ECM components such as collagen and elastin. Ultraviolet rays can stimulate the expression of MMPs, accelerate the destruction of the integrity of the dermis, and produce wrinkles. In addition, the epidermal oxidative stress and inflammatory response caused by ultraviolet rays can also induce keratinocytes to synthesize MMPs and secrete them into the dermis to act on collagen and elastin, thereby aggravating the degree of skin aging. Currently, common skin care products have a single protective effect on users, and there are insufficient reports on their anti-wrinkle effects.
[0004] Skin allergy is a kind of allergic reaction. When allergens enter the body, they prompt the body to produce corresponding antibodies, trigger antigen-antibody reactions, release inflammatory substances such as histamine and leukotrienes, and cause symptoms such as erythema, papules, itching, redness, swelling, dry scales, and blisters on the skin. With the pollution of air, environment, and food, as well as the excessive use of cosmetics, the human body's resistance to stimulation by foreign substances is getting worse and worse, and skin irritation and allergies are becoming more and more frequent. Hyaluronidase is a participant in type I allergic reactions. Hyaluronidase has a strong correlation with inflammation and allergies. Studies have reported that various drugs that release histamine from mast cells can regulate hyaluronidase activity, and some anti-allergic drugs have a strong inhibitory effect on hyaluronidase activity. Therefore, active ingredients that inhibit hyaluronidase activity can be used to fight skin allergies.
[0005] Hair contains a lot of protein, and the various chemical bonds between the protein chains maintain the strength and shape of the hair structure. Daily combing, blow-drying, perming, dyeing and bleaching often cause the load-bearing structure of the hair - the chemical bonds - to be broken, reduced or even broken, resulting in hair damage and a significant decrease in hair strength. However, most current hair care products focus on repairing the hair surface, and strengthening hair is still a very challenging task. Summary of the invention
[0006] Therefore, the technical problem to be solved by the present invention is to provide a use of a recombinant spider silk protein, wherein the recombinant spider silk protein has the effects of soothing the skin and resisting skin allergies, and can be used to prepare products that soothe the skin and resist skin allergies. At the same time, the recombinant spider silk protein also has the effects of anti-wrinkle and skin firming, and can be used to prepare products that anti-wrinkle and skin firming. In addition, the recombinant spider silk protein has the effect of improving the strength of hair bundles, and can be used to prepare products that improve the strength of hair bundles.
[0007] To this end, the present invention provides the following technical solutions:
[0008] A recombinant spider silk protein has any of the following uses:
[0009] (1) Use in the preparation of products for soothing skin and resisting skin allergies;
[0010] (2) Use in the preparation of skin anti-wrinkle and skin firming products;
[0011] (3) Use in the preparation of products for improving the strength of hair strands;
[0012] The amino acid sequence of the recombinant spider silk protein has the amino acid sequence shown in SEQ ID NO.1.
[0013] Optionally, the invention is used for preparing products for inhibiting hyaluronidase activity to soothe the skin and resist skin allergies.
[0014] Optionally, the invention relates to use of the invention in preparing products for inhibiting the activity of elastase to prevent wrinkles and tighten the skin.
[0015] Optionally, use in preparing a product for enhancing the tensile load and the total tensile work at break of a hair bundle to improve the strength of the hair bundle.
[0016] Optionally, the product includes cosmetics, skin care products, shampoo or hair care products.
[0017] Optionally, the product includes a cosmetic additive, a skin care product additive, a shampoo additive or a hair care product additive.
[0018] Optionally, in the product, the concentration of the recombinant spider silk protein is >0% v / v and ≤100% v / v.
[0019] Optionally, in the product, the concentration of the recombinant spider silk protein solution can be 0.01% v / v, 0.1% v / v, 1% v / v, 5% v / v, 6.25%, 10% v / v, 12.5%, 20% v / v, 25% v / v, 30% v / v, 40% v / v, 50% v / v, 60% v / v, 70% v / v, 80% v / v, 90% v / v or 100% v / v.
[0020] Optionally, in the product, the concentration of the recombinant spider silk protein is 1% v / v -50% v / v.
[0021] A cosmetic for soothing skin, resisting skin allergies, anti-wrinkle skin and / or tightening skin, comprising the recombinant spider silk protein and acceptable excipients; the concentration of the recombinant spider silk protein is >0% v / v and ≤100% v / v.
[0022] A skin care product for soothing the skin, resisting skin allergies, anti-wrinkle and / or tightening the skin, comprising the recombinant spider silk protein and acceptable excipients; the concentration of the recombinant spider silk protein is >0% v / v and ≤100% v / v.
[0023] A shampoo or hair care product for improving the strength of hair bundles, comprising the recombinant spider silk protein and acceptable auxiliary materials; the concentration of the recombinant spider silk protein is >0% v / v and ≤100% v / v.
[0024] The cosmetics for soothing skin, resisting skin allergies, anti-wrinkle skin and / or skin tightening, the skin care products for soothing skin, resisting skin allergies, anti-wrinkle skin and / or skin tightening, or the shampoo or hair care products for improving hair strength, the concentration of the recombinant spider silk protein is 0.01% v / v, 0.1% v / v, 1% v / v, 5% v / v, 6.25% v / v, 10% v / v, 12.5% v / v, 20% v / v, 25% v / v, 30% v / v, 40% v / v, 50% v / v, 60% v / v, 70% v / v, 80% v / v, 90% v / v or 100% v / v.
[0025] The technical solution of the present invention has the following advantages:
[0026] 1. A recombinant spider silk protein provided by the present invention has any of the following uses: (1) use in preparing a product for soothing the skin and resisting skin allergies; (2) use in preparing a product for anti-wrinkle and skin firming; (3) use in preparing a product for improving the strength of hair bundles; the amino acid sequence of the recombinant spider silk protein comprises any of the following: a. an amino acid sequence as shown in SEQ ID NO.1; b. an amino acid sequence having ≥90% homology with the amino acid sequence as shown in SEQ ID NO.1; the present invention has found that the recombinant spider silk protein has the effect of soothing the skin and resisting skin allergies, and thus can be used to prepare a product for soothing the skin and resisting skin allergies; the recombinant spider silk protein also has the effect of anti-wrinkle and skin firming, and thus can be used to prepare a product for anti-wrinkle and skin firming; in addition, the recombinant spider silk protein has the effect of improving the strength of hair bundles, and can be used to prepare a product for improving the strength of hair bundles. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0028] Figure 1 This is the result of the inhibition rate of hyaluronidase activity by the concentration gradient recombinant spider silk protein in Example 2 of the present invention;
[0029] Figure 2 is the result of the inhibition rate of elastase activity by the concentration gradient recombinant spider silk protein in Example 3 of the present invention;
[0030] Figure 3 is a comparison of the tensile load of the hair after the recombinant spider silk protein in Example 4 of the present invention was applied to the hair and that of the control group;
[0031] Figure 4 is a comparison of the total tensile breaking work of the hair after the recombinant spider silk protein in Example 4 of the present invention was applied to the hair and that of the control group;
[0032] In the above drawings, “ " indicates p<0.05; " " indicates p<0.01; " ” indicates p<0.001. DETAILED DESCRIPTION
[0033] The following examples are provided for a better understanding of the present invention, but are not intended to limit the best mode of implementation, nor to limit the content and protection scope of the present invention. Any product identical or similar to the present invention obtained by anyone under the inspiration of the present invention or by combining the features of the present invention with other prior arts shall fall within the protection scope of the present invention.
[0034] If no specific experimental steps or conditions are specified in the examples, the conventional experimental steps or conditions described in the literature in the field can be used. If no manufacturer is specified for the reagents or instruments used, they are all conventional reagent products that can be obtained commercially.
[0035] Example 1 Preparation of recombinant spider silk protein
[0036] 1. Construction of recombinant bacteria producing recombinant spider silk protein
[0037] 1.1. Target sequence synthesis: A gene synthesis company was commissioned to synthesize the gene sequence of the recombinant spider silk protein. Both ends of the gene sequence were connected with EcoRI / HindIII restriction site sequences (5'-cgaattc-3', 5'-caagcttg-3', respectively). The sequence is shown in SEQ ID NO.2.
[0038] 1.2. Insert the recombinant spider silk protein sequence into the vector plasmid pET28a by enzyme digestion and ligation assembly method. The detailed steps are as follows:
[0039] a. Insert fragment preparation:
[0040] i. After the synthesized fragments were digested by EcoRI / HindIII, the correct part was recovered by gel cutting. The digestion reaction system was as follows:
[0041] Table 1. Enzyme digestion reaction system configuration (50 μL)
[0042]
[0043] Note: 500 ng of PCR product was used for DNA fragments.
[0044] ii. Enzyme digestion reaction: After mixing the enzyme digestion system in the PCR tube, place the PCR tube into the PCR instrument and perform enzyme digestion at 37°C (optimal reaction temperature) for 1 hour.
[0045] iii. Use TIANgel Midi Purification Kit (commercially available) to perform fragment recovery operation.
[0046] iv. Detect the concentration of recovered fragments in an ELISA instrument.
[0047] b. Preparation of vector plasmid:
[0048] i. Take 1 μg of pET28a plasmid and digest it with EcoRI / HindIII (the digestion reaction system and digestion reaction conditions are the same as above), cut the gel to recover the correct part, and detect the concentration of the vector backbone fragment.
[0049] c. Target plasmid assembly:
[0050] i. Connection system:
[0051] Table 2. Connection system
[0052]
[0053] Note: T4 ligase / ligase buffer and BsaI used are all NEB brands.
[0054] ii. Connection conditions: Mix well after adding, and collect the solution at the bottom of the tube by short-speed centrifugation to avoid residual solution on the tube wall. Put the PCR tube into the PCR instrument and react at 16℃ for 1 hour.
[0055] d. Transformation and screening
[0056] 1) Conversion:
[0057] i. Use BL21 Chemically Competent Cell of Quanshigold brand as competent cells and thaw one tube on ice for 5 minutes.
[0058] ii. Take 10 μl of the assembly reaction solution, add it to 50 μl of competent cells, mix gently, and place on ice for 30 min.
[0059] iii. Heat shock in a 42°C water bath for 90 seconds.
[0060] iv. Immediately place on ice for 5 min, then add 500 μl of LB medium and culture at 37°C, 200 rpm on a shaking incubator for 1 h.
[0061] v. Take 200 μl of bacterial solution and spread it on a LB solid plate containing 50 mg / L kanamycin Kana, and culture it in a 37°C incubator for 24 h.
[0062] 2) Screening:
[0063] i. Pick 16 single colonies from the transformation plate, resuspend them in 10 μl sterile water in a 1.5 ml sterile tube, and mark the serial numbers.
[0064] ii. Take 1 μl for PCR verification, add the corresponding sequence number into 1 ml LB liquid culture medium containing 50 mg / L kanamycin, and culture at 37°C, 200 rpm shaking for 24 h.
[0065] Table 3. PCR verification primers
[0066]
[0067] iii. PCR amplification system - 50 μl: Using the plasmid for synthesizing the target gene as a template, the amplification system is as shown in Table 4:
[0068] Table 4. Amplification system
[0069]
[0070] iv. PCR amplification conditions are as shown in Table 5:
[0071] Table 5. Amplification conditions
[0072]
[0073] Note: Denaturation-annealing-extension was performed for 30 cycles.
[0074] v. Gel electrophoresis verification: Prepare 1% agarose gel; take 5 μl of PCR product and perform electrophoresis at 140 V for 20 minutes using 5000 bp DNA Maker as a reference; the target band is correct at around 1881 bp.
[0075] vi. Sequencing verification: In a 1.5 ml tube, take 0.4 ml of the bacterial solution with the correct target fragment, add 0.4 ml of 50% (v / v) glycerol, mix well, and store in a -80°C refrigerator. The remaining bacterial solution will be sent to BGI for sequencing verification using the verification primers Ver-F and Ver-R.
[0076] vii. Preservation of bacterial strains: Compare the sequencing results, retain the glycerol seed tubes with correct sequencing, and construct a plasmid labeled as pET28a-NT_2REP_CT.
[0077] 1.3. After the strain is constructed, take the glycerol tube and streak it on a LB solid medium plate containing 50 mg / L kanamycin, and culture it in a 37°C constant temperature incubator at 200 rpm. Pick a single clone and culture it in 4-5 mL LB liquid medium containing 50 mg / L kanamycin (Kana) at 37°C, 200 rpm shaking overnight;
[0078] 1.4. Transfer to a 400 mL shake flask for fermentation at 1% and culture at 200 rpm and 37°C for 2-3 h until OD 600 =0.6;
[0079] 1.5. Add isopropylthiogalactoside (IPTG) at a final concentration of 0.3 mM, induce at 20°C for 12-16 h, and collect the cells by centrifugation at 9000g for 5-10 min.
[0080] 2. Ultrasonic disruption of bacteria
[0081] (1) Add 20 mM Tris-HCl to dissolve the bacteria into a concentrated bacterial solution (40 mL) with an OD of about 20+.
[0082] (2) Ultrasound 25 kHz, power 70-80%, 3 seconds per ultrasound, 6 seconds off, for a total of 30 min;
[0083] (3) Centrifuge at 12,000 rpm for 10-15 min and collect the supernatant.
[0084] 3. Protein purification
[0085] (1) Repeat the supernatant after sonication by passing it through a packed nickel column 2-3 times and collect the flow-through;
[0086] (2) Wash the column material 3-5 times with 20 mM Tris-HCl (1-3 times the volume of the column material each time) until the dripping solution is clear;
[0087] (3) Wash the column material at least three times with 1-2 column volumes of pull-down buffer (commercially available) and collect the samples in sequence, which are recorded as E1, E2, and E3;
[0088] (4) Wash off the residual pull-down buffer with 5 column volumes of 20 mM Tris-HCl;
[0089] (5) If the column material needs to be stored for a long time after use, replace 20 mM Tris-HCl with 20% ethanol for storage.
[0090] 4. SDS-PAGE electrophoresis
[0091] (1) Prepare 10% separation gel according to the instructions of the SDS-PAGE gel preparation kit (Product No.: P0012A);
[0092] (2) Run the protein gel twice: the first gel run is to observe whether there are obvious target bands before and after induction during fermentation (if there are no target bands, the collected bacteria will not continue the protein purification step); the second gel run is to observe the eluate E1, E2, and E3 after elution, select the batch with obvious bands for dialysis, and observe the flow-through at the same time. If there is still obvious target protein in the flow-through, it means that secondary purification can be carried out, or the amount of column material can be increased for the protein supernatant of the same operation next time for overnight incubation.
[0093] 5. Dialysis of protein eluate and protein freeze-drying
[0094] (1) Pour the protein eluates E1 and E2 with obvious bands in the gel image into the same beaker and place them into the dialysis bag;
[0095] (2) Use pure water for dialysis, immerse the dialysis bag in water, change the water every 2-3 hours, and change the water 3-4 times;
[0096] (3) Quickly freeze the dialyzed protein solution with liquid nitrogen, place it in a -80°C refrigerator until the protein solution is completely solidified, and then place it in a freeze dryer to freeze-dry the protein;
[0097] (4) The lyophilized protein was weighed and sealed and stored under low temperature conditions. The obtained recombinant spider silk protein was sequenced and the sequencing was correct. Its amino acid sequence is shown in SEQ ID NO.1.
[0098] Example 2 Skin soothing and anti-skin sensitivity effects of recombinant spider silk protein
[0099] As is known to all, hyaluronidase is a participant in type I allergic reactions. Hyaluronidase is strongly correlated with inflammation and allergies. Studies have reported that various drugs that release histamine from mast cells can regulate hyaluronidase activity. Some anti-allergic drugs have strong inhibitory effects on hyaluronidase activity. Therefore, active ingredients that inhibit hyaluronidase activity can be used to combat skin allergies. Therefore, this example determines the effect of recombinant spider silk protein in inhibiting hyaluronidase activity, and it can be clarified that recombinant spider silk protein has the effect of soothing skin sensitivity.
[0100] (1) Preparation of recombinant spider silk protein solution. The recombinant spider silk protein prepared in Example 1 was dissolved in water to prepare recombinant spider silk protein with concentration gradients of 6.25% v / v, 12.5% v / v, 25% v / v, 50% v / v and 100% v / v (Note: the spider silk protein with a concentration of 100% is obtained by fermenting a strain expressing spider silk protein, extracting and purifying spider silk protein from the bacteria, and obtaining a 1.1 mg / ml solution of spider silk protein, i.e., a 100% (v / v) spider silk protein solution. Other concentrations are obtained by diluting the 100% (v / v) sample.) and refrigerated at 2-8°C for use as test samples;
[0101] (2) Mix 100 μL of hyaluronidase (Sigma, 500 U / mL), 100 μL of PBS buffer (Gibco, 100 mmol / L, pH=7, 37°C), 100 μL of NaCl (50 mmol / L), 100 μL of BSA (0.01%) and 50 μL of the test sample as the culture medium, and incubate at 37°C for 10 min in a shaker (Yiheng, THZ-25). The experimental group is the concentration gradient recombinant spider silk protein solution in (1), the blank control test sample is PBS (pH 7.0), and the positive control test sample is ascorbic acid (Sigma) (concentration is 2% w / v);
[0102] (3) Sodium hyaluronate (Huaxi Biotechnology) was dissolved in 300 mmol / L phosphate solution (pH = 5.35) to obtain a 0.03% w / v hyaluronic acid solution. 100 μL of hyaluronic acid solution was added to (2) as the start of the reaction and incubated at 37°C for 45 min.
[0103] (4) 0.1% bovine serum albumin (BSA) was dissolved in 24 mmol / L sodium acetate (Chinese medicine) and 79 mmol / L acetic acid (Chinese medicine, pH = 3.75) to obtain an acid albumin solution, which was added to each group of solutions treated in step (3), and the unhydrolyzed hyaluronic acid was precipitated with 1.0 mL of the acid albumin solution;
[0104] (5) After the precipitation mixture was placed at room temperature for 10 min, the absorbance of the mixture was measured at 600 nm using an ELISA reader (Tecan, Spark);
[0105] (6) All reagents should be freshly prepared before the enzyme reaction. The PBS group was used as the blank control (BC) and ascorbic acid (concentration of 2% w / v) was used as the positive control (PC). The percentage of inhibition was calculated as follows:
[0106] Inhibition rate (%) = (absorbance of sample group / absorbance of blank control group) × 100.
[0107] See Table 6 and Figure 1 In the hyaluronidase activity inhibition (biochemical method) experiment, compared with the blank control group, the sample recombinant spider silk protein showed a significant inhibitory effect on hyaluronidase activity at a concentration of 6.25%-100% (V / V) (p<0.05 or p<0.01), and has the effect of soothing the skin and anti-skin allergy.
[0108] Table 6. Summary of results of hyaluronidase activity inhibition rate
[0109]
[0110] Note: When using the t-test method for statistical analysis, the sample group, PC group and BC group were compared with each other. indicates that p-value<0.05 indicates that , p-value<0.01 is indicated as The concentration of spider silk protein in 100% (v / v) recombinant spider silk protein solution is 1.1 mg / ml.
[0111] Example 3 Recombinant spider silk protein has anti-wrinkle and skin firming effects
[0112] As we all know, elastase is the most important enzyme in the matrix metalloproteinase family. It is mainly synthesized and secreted by fibroblasts and can degrade elastin in the skin, leading to skin aging. By measuring the effect of recombinant spider silk protein in inhibiting the activity of elastase, it can be confirmed that recombinant spider silk protein has the effect of anti-wrinkle and skin firming.
[0113] (1) Preparation of recombinant spider silk protein solution. The recombinant spider silk protein prepared in Example 1 was dissolved in water to prepare concentration gradients of 6.25% v / v, 12.5% v / v, 25% v / v, 50% v / v and 100% v / v recombinant spider silk protein (Note: the spider silk protein concentration of 100% is obtained by fermenting a strain expressing spider silk protein, extracting and purifying spider silk protein from the bacteria, and obtaining a spider silk protein concentration of 1.1 mg / ml solution, i.e., 100% (v / v) spider silk protein solution. Other concentrations are obtained by diluting the 100% (v / v) sample.), and refrigerated at 2-8°C as test samples for later use;
[0114] (2) Preparation of reaction solution and method:
[0115] Blank sample: Tris-HCl buffer 140 μL;
[0116] The blank control was: Tris-HCl buffer 130 μL + elastase (1.1 U / mL) 10 μL;
[0117] The sample control was: Tris-HCl buffer 110 μL + recombinant spider silk protein sample 30 μL;
[0118] The sample is: Tris-HCl buffer 100 μL + elastase (1.1 U / mL) 10 μL + recombinant spider silk protein sample 30 μL;
[0119] The positive control (PC) was: 100 μL of Tris-HCl buffer + 10 μL of elastase (1.1 U / mL) + 30 μL of EGCG (concentration of 1 mg / ml).
[0120] After the above reaction solution was prepared, it was incubated in a shaker at 25°C for 20 minutes, and then 40 μL of AAAPVN (0.25 mg / mL) was added to each reaction solution and incubated in a shaker at 25°C for another 20 minutes. The absorbance at 410 nm was measured by a microplate reader. The calculation formula is as follows: Inhibition rate (%) = (1-(sample control-sample) / (blank control-blank sample))×100; AAAPVN is N-succinyl-alanine-alanine-alanine-p-nitroaniline.
[0121] See Table 7 and Figure 2 In the elastase activity inhibition (biochemical method) experiment, compared with the control group, the sample recombinant spider silk protein showed a significant inhibitory effect on elastase activity at a concentration of 6.25%-100% (V / V) (p<0.05 or p<0.01), which can be used as one of the evidences to verify the anti-wrinkle and firming effects.
[0122] Table 7. Summary of results of elastase activity inhibition rate
[0123]
[0124] Note: When using the t-test method for statistical analysis, the sample group, PC group and BC group were compared with each other. indicates that p-value<0.05 indicates that , p-value<0.01 is indicated as The concentration of spider silk protein in 100% (v / v) recombinant spider silk protein solution is 1.1 mg / ml.
[0125] Example 4 Recombinant spider silk protein has the effect of improving hair strength
[0126] This example investigates the effect of recombinant spider silk protein on improving hair strength, and the method is as follows:
[0127] (1) Obtaining an in vitro human hair bundle with specifications of 15-17 cm in length, 1.5 cm in width, and 2.5 g in weight;
[0128] (2) Two hair bundles were randomly divided into two groups, one in the control group and one in the sample group. Before the test, both groups were cleaned with 1 mL of 10% w / v SLES (sodium lauryl ether sulfate) solution (basic shampoo);
[0129] (3) According to the product instructions, apply about 0.5g of 100% (v / v) recombinant spider silk protein solution (the ratio of sample mass to hair mass is 1:5) evenly to the hair bundles in the sample group, leave it on for 1 minute, and then wash it clean. No product is used on the hair bundles in the control group, and the rest of the treatment is the same as the sample group. After completion, hang the hair bundles in a constant temperature and humidity chamber at 26±2°C and a relative humidity of 60±10% to dry and balance overnight; the concentration of spider silk protein in the 100% (v / v) recombinant spider silk protein solution is 1.1mg / ml solution;
[0130] (4) Thirty hairs were selected from the sample group and the control group respectively for sample preparation. The hair tensile mechanical properties were tested using the hair multifunctional testing system - single hair tensile test accessory (Single Fibre). The test indicators were tensile load and total tensile fracture work.
[0131] See Table 8, Figure 3 and Figure 4 , the tensile load and total tensile work at break of the control group and the sample group are listed respectively. It can be seen that the tensile load and total tensile work at break of the sample group are higher than those of the control group. SPSS software was used to statistically analyze the tensile mechanical properties of hair in the sample group and the control group. The test level α=0.05 showed that the tensile load and total tensile work at break of the sample group were significantly higher than those of the control group (tensile load p<0.001, total tensile work at break p<0.001), indicating that the test sample has the effect of improving the strength of the hair bundle. In summary, the test sample has the effect of preventing hair breakage (improving the strength of hair).
[0132] Table 8. Comparison of tensile load and total tensile fracture work
[0133]
[0134] Application Example 1
[0135] This application example provides a skin care product or cosmetic for soothing, anti-allergy and / or anti-wrinkle and firming skin, containing the recombinant spider silk protein solution prepared in Example 1, and the balance is deionized water or conventional excipients; the concentration of the recombinant spider silk protein solution is >0% v / v and ≤100% v / v, and further, the concentration of the recombinant spider silk protein solution can be 0.01% v / v, 0.1% v / v, 1% v / v, 5% v / v, 6.25% v / v, 10% v / v, 12.5% v / v, 20% v / v, 25% v / v, 30% v / v, 40% v / v, 50% v / v, 60% v / v, 70% v / v, 80% v / v, 90% v / v or 100% v / v. The concentration of spider silk protein in 100% (v / v) recombinant spider silk protein solution is 1.1 mg / ml solution.
[0136] Application Example 2
[0137] This application example provides a shampoo or hair care product for improving hair strength and preventing hair breakage, comprising the recombinant spider silk protein solution prepared in Example 1, and the balance being deionized water or conventional excipients; the concentration of the recombinant spider silk protein solution is >0% v / v and ≤100% v / v, and further, the concentration of the recombinant spider silk protein solution can be 0.01% v / v, 0.1% v / v, 1% v / v, 5% v / v, 6.25% v / v, 10% v / v, 12.5% v / v, 20% v / v, 25% v / v, 30% v / v, 40% v / v, 50% v / v, 60% v / v, 70% v / v, 80% v / v, 90% v / v or 100% v / v. The concentration of spider silk protein in 100% (v / v) recombinant spider silk protein solution is 1.1 mg / ml solution.
[0138] Obviously, the above embodiments are merely examples for the purpose of clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description. It is not necessary and impossible to list all the implementation methods here. The obvious changes or modifications derived from these are still within the scope of protection of the invention.
Claims
1. A use of a recombinant spider silk protein for any of the following purposes: (1) Use in the preparation of products for soothing skin and resisting skin allergies; (2) Use in the preparation of skin anti-wrinkle and skin firming products; (3) Use in the preparation of products for improving the strength of hair strands; The amino acid sequence of the recombinant spider silk protein is shown in SEQ ID NO.
1.
2. The use according to claim 1, wherein the product is a cosmetic.
3. The use according to claim 1, wherein the product is a skin care product.
4. The use according to claim 1, wherein the product is a shampoo or a hair care product.
5. The use according to claim 2, characterized in that: The product comprises a cosmetic additive.
6. The use according to claim 3, characterized in that: The product includes a skin care product additive.
7. The use according to claim 4, characterized in that The product comprises a shampoo additive or a hair care additive.
8. The use according to claim 1, characterized in that In the product, the concentration of the recombinant spider silk protein is 6.25% v / v, 12.5% v / v, 25% v / v, 50% v / v or 100% v / v.
